Opened in 1807, the University of Maryland, Baltimore (UMB) is Maryland’s public health, law, and human services university, dedicated to excellence in education, research, clinical care, and public service.

UMB enrolls over 7,100 students in six nationally ranked professional schools — dentistry, law, medicine, nursing, pharmacy, and social work — and an interdisciplinary Graduate School. The University offers 80 doctoral, master’s, baccalaureate, and certificate programs and confers most of the professional practice doctoral degrees awarded in Maryland.

UMB is a thriving academic health center combining cutting-edge biomedical research and exceptional patient care. UMB’s extramural funding totaled $688 million in Fiscal Year 2020, and each tenured/tenure-track faculty member brings $1.5 million in research grants, on average, into UMB every year.

UMB’s 14-acre BioPark is Baltimore’s biggest biotechnology cluster, with three dozen tenants and more than 1,000 employees. The research park fuels the commercialization of new drugs, treatments, and medical devices.

 

Living our Core Values

Accountability    Civility    Collaboration    Diversity    Excellence    Knowledge    Leadership

Mission

To improve the human condition and serve the public good of Maryland and society at-large through education, research, clinical care, and service.

Vision

The University will excel as a pre-eminent institution in its missions to educate professionals, conduct research that addresses real-world issues affecting the human condition, provide excellent clinical care and practice, and serve the public with dedication to improve health, justice, and the public good. The University will become a dominant economic leader of the region through innovation, entrepreneurship, philanthropy, and interdisciplinary and interprofessional teamwork. The University will extend its reach with hallmark local and global initiatives that positively transform lives and our economy. The University will be a beacon to the world as an environment for learning and discovery that is rich in diversity and inclusion. The University’s pillars of professionalism are civility, accountability, transparency, and efficiency. The University will be a vibrant community where students, faculty, staff, visitors, and neighbors are engaged intellectually, culturally, and socially. 

 

The Campus

Located in Baltimore, the campus consists of 71 acres with 6.5 million gross square feet of space in 62 buildings.

Degrees at UMB

Degrees icon

The University offers the following degrees:
  • 6 professional practice doctorate
  • 15 research and scholarship doctorate
  • 24 master's
  • 3 bachelor's
  • 22 postbaccalaureate certificate
  • 6 postdoctoral certificate
  • 4 certificate of advanced study

Browse academic programs.

Seven Schools, One University

SchoolYear Founded
School of Medicine 1807
Carey School of Law 1824
School of Dentistry 1840
School of Pharmacy 1841
School of Nursing 1889
Graduate School 1918
School of Social Work 1961

 

A student clad in a lab coat examining a microscope

 

Students - The Future of Care

Students icon

As the state’s only public health, law, and human services university, UMB confers the majority of professional practice doctoral degrees awarded in Maryland each year.

Student Demographics

69% In-State, 31% Out-of-State

73% Female, 27% Male

18% African American

45% Minorities

Enrollment by Program

87% Prof./Graduate, 13% Undergraduate

 # of students% of total
Nurses 853 12%
Dental Hygienists 28 0.4%
Medical and Research
Technologists
17 0.2%
Undergraduate Total 898 13%
Biomedical 1,406 20%
Nurses 1,233 17%
Social Workers 966 13%
Lawyers 753 11%
Physicians 622 9%
Dentists 580 8%
Pharmacists 479 7%
Physical Therapists 200 3%
Prof./Graduate Total 6,239 87%
Total - Fall 2020 7,137 100%

 

National Rankings

Dentistry 4th NIH Funding (Publics) FY 2020
Medicine 16th

Primary Care-U.S. News & World Report (2021)

Law    

Three specialties in top 10 in U.S. News & World Report (2021), with Part-Time Law 8th, Clinical Training 9th, and Health Care Law 7th.

Nursing   

Two specialties in top 10 in U.S. News & World Report (2021), with Doctor of Nursing Practice-Adult/Gerontology Primary Care 6th and Doctor of Nursing Practice-Family 8th.

Pharmacy 14th U.S. News & World Report (2020)
Social Work 17th U.S. News & World Report (2019)


For more information, contact the UMB Government Affairs Office at 410-269-5087. 

 Foundations of Excellence

History

1807

The Maryland General Assembly chartered the College of Medicine in 1807; it is now the nation’s oldest public medical school.

 

1812

In 1812, the Maryland General Assembly rechartered the College of Medicine as the University of Maryland and expanded its mission.

 

1824

The forerunner of the law school, the Maryland Law Institute, was opened in 1824.

 

1840

The world’s first dental college, the Baltimore College of Dental Surgery, was chartered in 1840.

 

1841

The following year in 1841, the Maryland General Assembly chartered the College of Pharmacy, making it the fourth-oldest pharmacy school in the nation.

 

1889

In 1889, Louisa Parsons, a colleague of Florence Nightingale, established the School of Nursing, one of the nation’s oldest formal nursing training programs, at the University of Maryland.

 

1918

To promote and enhance research, scholarship, and advanced study, the Graduate School opened in 1918.

 

1961

In response to growing social and cultural needs, the School of Social Work opened in 1961.

 

Community Service

Students, faculty, and staff contribute more than 2 million hours of service annually to citizens throughout Maryland, providing programming that improves health and wellness, advances justice, promotes economic development, and strengthens families and communities.

Employment - Fall 2020

Faculty 3,033
Executive/Professional 2,585
Support Personnel 1,357
Total Regular Employees 6,975
Student Employees 781
Total Employees 7,756

 

Join our diverse workforce and help us make a difference in our community and the world.

Equal Opportunity

The University of Maryland, Baltimore (UMB) does not discriminate on the basis of race, color, religion, national origin or ancestry, sex, sexual orientation, gender identity or expression, physical or mental disability, marital status, protected veteran's status, or age in its programs and activities.

Specifically, Title IX prohibits discrimination on the basis of sex in UMB’s programs and activities.

Driving the Economy

Dramatic Achievements
  • Fiscal Year 2020: Awarded $688 million in grants and contracts
  • Yield: $1.5 million research dollars per core faculty
Return on Investment
  • Yields $13 in economic activity for each $1 of state general fund appropriation
  • Generates more than 17,000 jobs
  • Together with the University of Maryland Medical Center and affiliated physician practices, generates $7.9 billion in annual economic activity

An Entrepreneurial Campus

FY 2020 - Sources of Funds
Research Grants and Contracts 41%
Clinical (Patient) Care 25%
State Funds 19%
Tuition and Fees 11%
Auxiliary Fees 4%
Total: $1.33 Billion 100%

 
See the Office of Institutional Research and Planning for more data.

 

Engagement in Baltimore

  • The new UMB Community Engagement Center (CEC), adjacent to campus and almost seven times larger than the original CEC, provides direct health, employment, legal, and social services to West Baltimore residents, and works with them on neighborhood-strengthening projects.
  • The UMB CURE Scholars Program is a long-term mentoring initiative designed to excite West Baltimore middle and high school students about science and begin preparing them for rewarding careers in research and health care.
  • The School of Social Work operates Promise Heights, a network of partnerships and services intended to stabilize and strengthen families in a high-need West Baltimore neighborhood and help children succeed in school.
  • The Partnership with West Baltimore is a collaboration between UMB and the University of Maryland Medical Center designed to improve population health, stimulate economic and community development, boost academic achievement, and nurture community connections.

 

See the exciting progress we're making as a University – seven schools working to secure the health, well-being, and just treatment of people across the state and around the world.

 

Health and Legal Care

Medicine

  • Attending physicians at the University of Maryland Medical Center are faculty members of the School of Medicine (SOM).
  • A record 163 of SOM physicians were named “Top Docs” by Baltimore magazine in 2020.
  • Research funding in Fiscal Year 20 totaled $563 million, the highest total ever.
  • SOM researchers applied for $193 million in COVID-19 related research, with $32 million awarded, including vaccine trials with the leading Pfizer and Moderna vaccine candidates.
  • SOM created a high throughput laboratory for COVID-19 testing and completed more than 300,000 tests for the state’s universities, nursing homes, correctional facilities, and urgent care centers.
  • SOM’s Kathleen Neuzil, MD, MPH, was named The Baltimore Sun’s 2020 Marylander of the Year for her outstanding leadership and impact in vaccine testing and therapeutics for COVID-19.
  • In 2020, SOM completed its Special Trans-Disciplinary Recruitment Award Program, which attracted 26 teams of scientists from leading institutions across the United States and brought in an additional $101 million in research funding to the school.

Dentistry

  • The only dental school in Maryland also is the largest provider of oral health services to Medicaid children/HIV patients.
  • More than 23,000 patients are treated and 95,000 patient visits are recorded each year.
  • Founded in 1840, it is the world’s first dental college.

Carey Law

  • Each year, 150 Carey Law students provide nearly75,000 hours of free legal services through 17 legal clinics, making the Clinical Law Program one of the region's largest public interest law firms.

Nursing

  • The nurse’s clinic at Paul’s Place, a community outreach center in Southwest Baltimore, provided 208 intensive clinical case management visits and 165 outreach encounters with patients in FY20. As a result, the clinic — run by associate professor Kelly Doran, PhD ’11, MS ’08, RN — was able to divert 96 percent of nonemergent cases to an appropriate nonemergent care facility. The clinic serves as a clinical placement for nursing and medical students at UMB.

Pharmacy

  • In 2019, the Maryland Poison Center received 36,245 calls.
  • Faculty and staff provide clinical service to approximately 35,000 patients each year in more than 24 practice settings in specialties such as community pharmacy, cardiology, oncology, pediatrics, HIV/AIDS, mental health, diabetes, geriatrics, and palliative care.
  • In 2018, the School of Pharmacy launched the MS in Medical Cannabis Science and Therapeutics, the nation’s first graduate program focused on the study of medical cannabis.

Social Work

  • More than 800 social work students provide over 500,000 hours of care to Maryland citizens annually.

 

Commercial Potential

In Fiscal Year 20, UM Ventures — the joint technology transfer enterprise of UMB and the University of Maryland, College Park  — accelerated the translation of research into market-ready technologies and therapies that improve health, wellness, safety, and productivity.

Commercialization of technology at UMB alone was substantial with:

  • 274 new patent filings
  • 35 new license agreements
  • seven new startup companies
  • two UM Ventures investment portfolio company acquisitions
  • one new UM Ventures investments in UMB startup

UMB technologies and startups are making significant strides in achieving regulatory approvals and raising funding. Recent successes include:

  • Breethe, a UMB startup developing the world’s first portable artificial lung system, was acquired by Abiomed in April 2020. Breethe received early investment from UM Ventures and raised more than $16 million in funding after the company was founded in 2015.
  • SurgiGYN, a medical device company developing a uterine electrosurgical device to improve the safety and ease of total laparoscopic hysterectomy, was acquired in early 2020 by a leading global medical device company. UM Ventures provided early investment in the technology and the New Ventures Initiative team managed SurgiGYN, advancing the device to acquisition.
  • Protaryx, a medical device startup developing a device to access the left atrium for transcatheter cardiac procedures, closed a $5.1 million Series A funding round led by Ajax Health and with participation from UM Ventures. In total, Protaryx has raised $8.3 million in funding.
  • GEn1E Lifesciences, a startup developing therapeutics for inflammatory and age-related diseases, licensed UMB’s p38a kinase inhibitor program after vetting the technology in fall 2019. UM Ventures invested in the inhibitor program, helping advance it to a licensable stage. GEn1E closed a $3 million funding round in early 2020.
  • Isoprene Pharmaceuticals, a therapeutic startup developing novel small molecules for the treatment of cancer, sublicensed its technology to Hoth Therapeutics in spring 2020. Isoprene’s technology has received UM Ventures investment, and the company is managed by the New Ventures Initiative team.

UM Ventures also provides tailored funding, educational programs, and other resources that strengthen the commercialization of high-potential University-based discoveries, with specific efforts to encourage University-created or -sponsored technology companies to locate in Baltimore City. Highlights include:

  • The Maryland Momentum Fund, a $10 million early-stage investment program investing in University System of Maryland-affiliated companies, has invested $4.7 million in 16 companies with $21 million in matching funds from more than 20 co-investors. Five UMB-affiliated companies have received investment: NextStep Robotics, NeoProgen, Veralox, KaloCyte, and ARMR Systems.
  • The Baltimore Fund has encouraged the expansion and location of 18 companies in qualifying areas, creating or retaining more than 400 jobs.
  • The Life Sciences IP Fund has assisted 21 early-stage technologies, including 10 device and 11 therapeutic technologies, in moving toward commercialization. Three new UMB startups — Isoprene Pharmaceuticals, Protaryx, and GEn1E Lifesciences — have been formed as a result of the program.

The 14-acre University of Maryland BioPark, home to more than 1,000 employees, provides sophisticated lab and office space for nearly three dozen early-stage life science companies, University-based startups, and sophisticated bioscience industry leaders such as Illumina, Catalent, and Pharmaron.

 

 


 

For more information, contact the University of Maryland, Baltimore Government Affairs Office at 410-269-5087.

Produced by the Office of Communications and Public Affairs, updated January 2021. Download UMB Fast Facts as a PDF.

The University of Maryland, Baltimore does not discriminate on the basis of race, color, religion, national origin or ancestry, sex, sexual orientation, gender identity or expression, physical or mental disability, marital status, protected veteran’s status, or age in its programs and activities. Specifically, Title IX prohibits discrimination on the basis of sex in UMB’s programs and activities.